GOSS is a biotechnology penny stock without earnings valued based on future earnings
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line of the long-range volume profile. The RSI indicator is
now showing a bearish divergence as the relative strength is weakening. Price has bounced
down from the resistance of the line representing two standard deviations above VWAP.
The supply / demand zones are indicated by the Indicator applied which is authored by
Luxalgo. Price has hit the supply zone lower border and is now in an early reversal.
I see this as a swing short trade also played with taking put options. Stop loss is
in the upper area of the red supply zone. Targets include first the POC line of the volume
profile and then a final target at one STD below VWAP also being just above the demand zone.
Alternatively put options at the strike of $ 1.50 for the May monthly expiration of 5/18
This trade will benefit from any expected pullback in the general markets.
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line of the long-range volume profile. The RSI indicator is
now showing a bearish divergence as the relative strength is weakening. Price has bounced
down from the resistance of the line representing two standard deviations above VWAP.
The supply / demand zones are indicated by the Indicator applied which is authored by
Luxalgo. Price has hit the supply zone lower border and is now in an early reversal.
I see this as a swing short trade also played with taking put options. Stop loss is
in the upper area of the red supply zone. Targets include first the POC line of the volume
profile and then a final target at one STD below VWAP also being just above the demand zone.
Alternatively put options at the strike of $ 1.50 for the May monthly expiration of 5/18
This trade will benefit from any expected pullback in the general markets.